Follow
Lipidor AB
Nasdaq First North Sweden (Sweden)
Lipidor is a pharmaceutical development company with a pipeline of drug development projects in preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis. With Lipidor’s patented formulation technology AKVANO, well-proven drugs, whose patent time has expired or will expire, can be reformulated and improved in terms of efficacy, side effects, and ease of use (so-called supergenerics).
Sector:
HEALTH CARE
>
Pharmaceuticals
Media
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
LIPI
SE0012558617
Nasdaq First North Sweden
Sweden (SE)
Details of share in Lipidor AB with ticker LIPI
Status
Active
Order book id
Amount of instruments
Par value
500.0000
Market cap
Currency
SEK
First trading date
27 Sep 2019
Terms
One (1) unit contain two (2) shares and one (1) free warrant.
Type
Price
Pre-money valuation
Time
IPO
6.00 SEK
116M SEK
28 Aug - 13 Sep 2019
IPO in Lipidor AB
Market
Nasdaq First North Sweden
Subscription period
28 Aug - 13 Sep 2019
Subscription price
12.00 SEK
Price per share
6.00 SEK
Target to raise
25 200 000 SEK
Types
Share issue
Pre-money valuation
116 000 000 SEK
Subscription block size
1
Minimum subscription
500
Record date
26 Aug 2019
Offer status
Closed
Listing status
Upcoming
First trading date
27 Sep 2019
Issue terms
One (1) unit contains two (2) shares and one (1) free warrant.
Result of offer
The issue of approximately SEK 25.2 million was subscribed at SEK 136 million, corresponding to a subscription rate of circa 540%. Through the share issue, the company will add circa 1,150 new shareholders.
Type
Ticker
ISIN
Market
OPTION
LIPI TO1
SE0012677177
Nasdaq First North Sweden
Sweden (SE)
Details of option in Lipidor AB with ticker LIPI TO1
Status
Active
Order book id
Amount of instruments
Market cap
Currency
SEK
First trading date
27 Sep 2019
Terms
A Subscription warrant entitles to subscribe for a newly issued share in the Company at a subscription price per share equal to 70 percent of a volume weighted average of the trading price of the Company's shares at Nasdaq First North during September 29 - October 13, 2020. However, the subscription price per share when exercising a Warrants may not be less than SEK 9 per share or exceed SEK 12 per share.
Type
Price
Pre-money valuation
Time
Exercise
9.00-12.00 SEK
-
16 Oct - 03 Nov 2020
Option exercise terms for LIPI TO1
Market
Nasdaq First North Sweden
Exercise period(s)
16 Oct - 03 Nov 2020
Exercise price range
9.00-12.00 SEK
Exercise final price
Status
Upcoming
Issue terms
A Subscription warrant entitles to subscribe for a newly issued share in the Company at a subscription price per share equal to 70 percent of a volume weighted average of the trading price of the Company's shares at Nasdaq First North during September 29 - October 13, 2020. However, the subscription price per share when exercising a Warrants may not be less than SEK 9 per share or exceed SEK 12 per share.
People
Ola Holmlund
CEO
Magnus Hedman
Chairman of the board
Ola Flink
Board member
Gabriel Haering
Board member
Gunilla Lundmark
Board member
Fredrik Sjövall
Board member
Per Nilsson
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O Karolinska Institutet Fogdevreten 2
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
5567797500
LEI code
549300OC9DDXCE1GMX60
First trade date
27 Sep 2019
Registration date
20 Mar 2009
Short name
Lipidor